Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and Vomiting

ConditionPost-operative Nausea and Vomiting (PONV)

Trial statusNot yet recruiting

Trial phasePhase 3

Trial typeInterventional

Biological sexAll

Age18-75

SponsorCSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.

About this trial

A randomized, double-blind, placebo-controlled, multi-center phase III study to compare the efficacy and safety of aprepitant injection and placebo in the prevention of post-operative nausea and vomiting (PONV).,

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

Aprepitant Injection
Aprepitant Injection Placebo

Treatment groups

486 Participants

are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.

Lead sponsor

Source ClinicalTrials.gov